BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu L, Tu Y, Li J, Zhang W, Wang Z, Zhuang C, Xue L. Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury. Chinese Chemical Letters 2022;33:2545-9. [DOI: 10.1016/j.cclet.2021.09.059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z. Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease. ACS Chem Neurosci 2022. [PMID: 35607807 DOI: 10.1021/acschemneuro.2c00172] [Reference Citation Analysis]
2 Liu G, Hou R, Xu L, Zhang X, Yan J, Xing C, Xu K, Zhuang C. Crystallography-Guided Optimizations of the Keap1-Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides. J Med Chem 2022;65:8289-302. [PMID: 35687391 DOI: 10.1021/acs.jmedchem.2c00170] [Reference Citation Analysis]